Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes

Table 1

Baseline of the recruited subjects.

Items	All	Group by sex
	Male/female (52/50)	Male (52)	Female (50)	value
Age (yrs.)				0.47
BMI (kg/m^2)				0.20
Waistline (cm)				0.46
Hipline (cm)				0.76
Waist-to-hip ratio (%)				0.49
TDD1 (U/kg)				0.001
Bolus (U/kg)				0.01
Basal (U/kg)				0.001
TDD2 (U/kg)				0.001
BI (U/kg)				0.01
LI (U/kg)				0.01
DI (U/kg)				0.001
Duration (yrs.)				0.57
HbA1c (%)				0.41
C-peptide 0 (pmol/L)				0.75
C-peptide 120 (pmol/L)				0.16

, male vs. female; , male vs. female. BMI: body mass index; TDD: total daily dose; BI: breakfast insulin dose; LI: lunch insulin dose; DI: dinner insulin dose; C-peptide 0: C-peptide level after glucose loading at 0 min; C-peptide 120: C-peptide level after glucose loading at 120 min.